Synthesis of C2-symmetric (S,S)-1,4-dibenzyl-DTPA and 1,4-meso-dibenzyl-DTPA via chiral diamines

Tetrahedron

Volumn 52, Issue 46, 1996, Pages 14507-14514

  Sajiki, Hironao ^a,b   Ong, Karen Y ^a  

^a Metasyn Inc ^*  (United States)

^b GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIBENZYLPENTETATE; PENTETIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; DRUG STRUCTURE; DRUG SYNTHESIS; MASS SPECTROMETRY; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; REACTION ANALYSIS;

EID: 0030580425     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/0040-4020(96)00896-4     Document Type: Article

References (27)

1. 1 For general review of contrast agents in MRI, see: (a) Lauffer, R. B. Chem. Rev. 1987, 87, 901.
2. (b) Watson, A. D.; Rocklage, S. M.; Carvlin, M. J. In Magnetic Resonance Imaging; 2nd ed.; Stark, D. D., Bradley, W. G.; Eds.; Mosby Year Book: St. Louis, 1992; Chapter 14; pp. 372-437.
3. 2 Lauffer, R. B. Magn. Reson. Med. 1991, 22, 339 and references cited therein.
4. 3 For example, (a) Felder, E.; Uggeri, F.; Fumagalli, L.; Vittadini, G. U.S. Patent 4916246 1987.
5. (b) Vittodini, G.; Felder, E.; Tirone, P.; Lorusso, V. Invest. Radiol. 1988, 23, S 246.
6. (c) Geraldes, C. F. G. C.; Sherry, A. D.; Cocheris, W. P.; Kuan, K.-T.; Brown, R. D., III; Koenig, S. H.; Spiller, M. Magn. Reson. Med. 1988, 8, 191.
7. (d) Konings, M. S.; Dow, W. C.; Love, D. B.; Raymond, K. N.; Quay, S. C.; Rocklage, S. M. Inorg. Chem. 1990, 29, 1488.
8. (e) Schmitt-Willich, H.; Platzek, J.; Heinz, G.; Schuhmann-Giampieri, G.; Vogler, H.; Weinmann, H.-J. Eur. Patent 045704 1990.
9. (f) Brechbiel, M.; Gansow, O. A. J. Chem. Soc., Perkin Trans. 1 1992, 1173.
10. Recently, an applicable synthetic method of DTPA derivatives having a second functional group at the α-position of an acetic acid moiety was reported, see: (g) Nemoto, H.; Cai, J.; Yamamoto, Y. Tetrahedron Lett. 1996, 37, 539.
11. 4 Schmitt-Willich, H. Platzek, J., Gries, H., Schuhmann-Giampieri, G., Vogler, H., Weinmann, H. Eur. Pat., Appl., EP 0405704 (Appl. 90/250165, June 27, 1990).
12. 5 For example, (a) Brechbiel, M. W.; Gansow, O. A.; Atcher, R. W.; Schlom, J.; Esteban, J.; Simpson, D. E.; Colcher, D. Inorg. Chem. 1986, 25, 2772 and references cited therein.
13. (b) Cummins, C. H.; Rutter, E. W. Jr.; Fordyce, W. A. Bioconjugate Chem. 1991, 2, 180.
14. (c) Brechbiel, M. W.; Gansow, O. A.; Bioconjugate Chem. 1991 2, 187.
15. (d) Mirzadeh, S.; Brechbiel, M. W.; Atcher, R. W.; Gansow, O. A. Bioconjugate Chem. 1990, 1, 59.
16. 6 Peters, T. Human Serum Albumin, Adv. Protein Chem. 1985, 37, pp 161-245.
17. 7 (a) Fehrentz, J.-A.; Castro, B. Synthesis 1983, 676.
18. (b) Skiles, J. W.; Miao, C.; Sorcek, R.; Jacober, S.; Mui, P. W.; Chow, G.; Weldon, S. M.; Possanza, G.; Skoog, M.; Keirns, J.; Letts, G.; Rosenthal, A. S. J. Med. Chem. 1992, 35, 4795.
19. 15; Unpublished result. A similar synthetic method for the chelating agents was also reported by Meares et al., see: Meares, C. F.; Goodwin, D. A. J. Protein Chem. 1984, 3, 215, and references cited therein.
20. 9 (a) Dicman, D. A.; Meyers, A. I.; Smith, G. A.; Gawley, R. E. Org. Synth., Coll. Vol. VII 1990, 530.
21. (b) For review on the 1,2-amino alcohols as chiral auxiliaries in asymmetric synthesis, see: Ager, D. J.; Prakash, I.; Schaad, D. R. Chem. Rev. 1996, 96, 835.
22. 10 Sajiki, H.; Ong, K. Y.; Nadler, S. T.; Weges, H. E.; McMurry, T. J. Synth. Commun. 1996, 26, 2511 and references cited therein.
23. 11 Still, W. C.; Kahn, M.; Mitra, A. J. Org. Chem. 1978, 43, 2923.
24. 12 Lindlar, L.; Dubuis, R. Org. Synth., Coll. Vol. V 1973, 880.
25. 13 Brown, H. C.; Heim, P. J. Org. Chem. 1973, 38, 912.
26. 14 Skidmore, W. D. and Entenman, C., J. Lipid Res. 1962, 3, 471.
27. 15 On leave from Research & Development Center, Nipponshoji Kaisha, LTD., Osaka, Japan (December, 1992 - May, 1993).